International Patent: MODIFIED AMINOACYL-TRNA SYNTHETASE, NUCLEIC ACID CONSTRUCT AND GENETICALLY ENGINEERED STRAIN

GENEVA, Aug. 14 -- KANGMA-HEALTHCODE (SHANGHAI) BIOTECH CO., LTD filed a patent application (CN2024/142051) for “MODIFIED AMINOACYL-TRNA SYNTHETASE, NUCLEIC ACID CONSTRUCT AND GENETICALLY ENGINEERED STRAIN”. With publication no. WO/2025/140227, here are the other details related to the patent application:

Kind: Corrected version of pamphlet [A9]

IPC: C12N 9/00

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....